IRM
75
2
TROW
37
3
CSCO
67
4
VLO
30
2
GD
60
3
AMP
72
2
PDCO
46
3
VZ
44
2
ROST
52
2
ZTS
49
2
NWS
47
2
NOC
45
5
CVX
32
3
BAC
54
3
DUK
55
6
EMR
54
4
FLR
66
11
DHR
47
-3
CMS
57
2
PX
63
3
IRM
75
2
TROW
37
3
CSCO
67
4
VLO
30
2
GD
60
3
AMP
72
2
PDCO
46
3
VZ
44
2
ROST
52
2
ZTS
49
2
NWS
47
2
NOC
45
5
CVX
32
3
BAC
54
3
DUK
55
6
EMR
54
4
FLR
66
11
DHR
47
-3
CMS
57
2
PX
63
3
Financhill
Back

ProShares UltraPro Russell2000 Vs. Kymera Therapeutics Industry Stock Comparison

Buy
72

URTY
ProShares UltraPro Russell2000

Last Price:
55.46
Seasonality Move:
24.23%
Buy
71

KYMR
Kymera Therapeutics

Last Price:
46.27
Seasonality Move:
65.72%
Buy
72
ProShares UltraPro Russell2000 (URTY) is a Buy

Is ProShares UltraPro Russell2000 a Buy, Sell or Hold?

  • The current ProShares UltraPro Russell2000 [URTY] share price is $55.87. The Score for URTY is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
  • URTY is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
71
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $49.02. The Score for KYMR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

URTY Stock Price Chart

What is ProShares UltraPro Russell2000's stock price today?

  • The ProShares UltraPro Russell2000 share price today is $55.87
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and URTY is experiencing buying pressure, which is a positive indicator for future bullish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $49.02
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

URTY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.05 Buy
Relative Strength Index (14 RSI): 65.43 Buy
Chaikin Money Flow: 504635 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (48.99 - 52.95) Buy
Bollinger Bands (100): (43.09 - 52.41) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 59.12 Buy
Chaikin Money Flow: 317205 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.81 - 49.49) Buy
Bollinger Bands (100): (34.86 - 47.92) Buy

URTY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 51.56 Buy
20-day SMA: 51.34 Buy
50-day SMA: 48.99 Buy
200-day SMA: 45.93 Buy
8-day EMA: 52.44 Buy
20-day EMA: 51.14 Buy
50-day EMA: 49.77 Buy
200-day EMA: 46.15 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.58 Buy
20-day SMA: 46.67 Buy
50-day SMA: 46.11 Buy
200-day SMA: 38.62 Buy
8-day EMA: 45.67 Buy
20-day EMA: 45.85 Buy
50-day EMA: 45.2 Buy
200-day EMA: 38.5 Buy

ProShares UltraPro Russell2000 Earnings Growth & URTY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.

ProShares UltraPro Russell2000 Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):